Under terms of the agreement, which took effect Jan. 1, FHS became the sole owner of GICH. The hospital, however, was able to maintain its 15-member board of directors, with three members representing FHS’ interests, according to the article. GICH’s board of directors also maintain the option to terminate the partnership if officials no longer believe the collaboration to be beneficial for the hospital.
Mr. Youso told the Herald-Review there will be no staffing changes on account of the partnership.
In the first year of the partnership, officials said the institutions will collaborate on EHR migration, payer contract negotiations, legal, risk and compliance support, revenue cycle management, supply chain improvements and a joint regional growth strategy, according to the report.
More articles on transactions and valuations:
Viewpoint: Philadelphia Refugee Health Collaborative aims to deliver improved healthcare to refugees
Norton Cancer Institute, Churchill Downs partner on local women’s breast health program
Massena Memorial officials still undecided on potential affiliate
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
